BioAnalix Inc.

BioAnalix Inc. is a Toronto company working on two fronts.

The first is protein and enzyme engineering. Our platform pairs high-throughput experimental screening with machine-learning models that predict stabilizing mutations, running as a closed design-build-test-learn cycle. It serves university and hospital research groups in Canada and the United States.

The second is rare disease. We are developing patient-derived human cell assays that measure whether a candidate therapy has produced the biological effect it was designed to produce, in partnership with an academic laboratory at the University of Calgary.

Contact: Ahmad Rezaei (Founder) Ahmad@bioanalix. or info@bioanalix.ca